Aristotle University Of Thessaloniki (AUTH)
Μελέτη της μεταγωγής σήματος από τους υποδοχείς του TNF και χαρακτηρισμός της πρωτεΐνης USP31
Abstract
dc:descriptionThe tumor necrosis factor superfamily of cytokines and receptors (TNF/TNFR) activate signalling pathways for cell proliferation, differentiation and apoptosis. CD40 Receptor is a member of the Tumor Necrosis Factor Receptors (TNFR) and is expressed mainly on the surface of B lymphocytes. CD40 interacts with CD40 Ligand (CD154) which is expressed mainly on T lymphocytes. LMP1 is a pseudoreceptor of the TNFR superfamily which mimics CD40 signalling and is constitutively activated. TRAFs constitute a family of proteins that participate in signal transduction by members of the TNF receptor superfamily. The amino terminal region of TRAFs is rich in cysteine and histidine residues, arranged in putative zinc-finger motifs and a more complex RING finger motif. TRAF2 and TRAF6 have a ubiquitin ligase activity which is dependent on the integrity of their RING finger domain and has been associated with the ability to activate the NF-κB and AP1 signalling pathways. Protein modification by ubiquitination has been primarily associated with degradation by the proteasome. However, protein ubiquitination has also been implicated in other cellular functions, including cell cycle regulation, signal transduction, transcription regulation, receptor endocytosis, ribosomal function etc. In previous studies of our research team, a yeast two-hybrid screening was performed in order to elucidate further the TRAF2 signalling mechanism. One of the isolated proteins demonstrated a strong positive interaction with wild type TRAF2, but very weak or no interaction with a mutant TRAF2 at the RING finger domain. This protein was studied further and turned out to be identical to a ubiquitin specific protease named USP31. Comparison of the USP31 cDNA sequence with human ESTs revealed that at least two USP31 cDNAs exist. One cDNA encodes for a 1035-amino-acid long polypeptide (USP31, long isoform) whereas the other encodes for a 485-amino-acid long polypeptide (short isoform, USP31S1). The two isoforms of USP31 share a common amino terminal region of 483 amino acids and contain all eight characteristic motifs of known deubiquitinases. Northern blot analysis of normal tissues and cancer cell lines revealed two major mRNA species of approximately 4.4 and 2.4 kb. The 4.4 kb mRNA was expressed in all normal tissues and cancer cell lines tested, while the 2.4 kb mRNA was expressed only in cancer cell lines. These mRNAs are likely to be derived from alternative splicing and may code for USP31 and USP31S1 respectively. USP31 was examined for its ability to act as a ubiquitin specific protease (USP/UBP). In addition to wild type USP31, a point mutant containing a serine instead of cysteine at position 98 (USP31C98S) was constructed and tested for its enzymatic activity. Cysteine-98 corresponds to a highly conserved cysteine of the catalytic domain of deubiquitinating enzymes (Cys box). USP31, USP31C98S and USP31S1 were tested for their ability to cleave tetraubiquitin in vitro. Wild type full length USP31 readily cleaved the tetrameric substrate to its monomer, dimer and trimer. However, the point mutant USP31C98S and the short isoform USP31S1 were enzymatically inactive. Furthermore, USP31 was tested for its deubiquitinating specificity towards lysine-48 or lysine-63-linked polyubiquitin chains. Lysine-48-linked polyubiquitin chains usually mark proteins for proteasomal degradation whereas lysine-63-linked polyubiquitin chains have been associated primarily with non-proteolytic regulatory processes. Wild type USP31 cleaved almost completely lysine-63-linked polyubiquitin. Moreover, it cleaved partially lysine-48-linked polyubiquitin. The point mutant USP31C98S or the short isoform USP31S1 did not cleave any of the two substrates. These results demonstrate that USP31 is a deubiquitinating enzyme that cleaves preferentially lysine-63-linked polyubiquitin chains. USP31 can also cleave lysine-48-linked polyubiquitin chains albeit to a lesser extent. The ability of USP31 to interact with TRAF2 in mammalian cells was tested by co-immunoprecipitation experiments in HEK 293T cells. These experiments confirmed the specific interaction of USP31 and TRAF2 which requires an intact RING finger domain of TRAF2. Indirect immunofluorescense showed that USP31 is localized predominantly in the nucleus and to some extent in the cytoplasm. .................................................................................................
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Τζήμας, Χρίστος
- Tzimas, Christos
Subjects
dc:subject × 20- Παράγοντας ογκονέκρωσης
- Μεταγωγή σημάτων
- Παράγοντες που σχετίζονται με τους υποδοχείς του παράγοντα ογκονέκρωσης
- Υποδεοχείς παράγοντα ογκονέκρωσης
- Ουβικιτίνη
- Πρωτεϊνικές λιγάσες ουβικιτίνης
- Ένζυμα αποουβικιτίνωσης
- Ειδικές πρωτεάσες ουβικιτίνης
- Tumor necrosis factor (TNF)
- Signal transduction
- Tumor necrosis factor receptors associated factors
- Tumor necrosis factor receptors
- Ubiquitin
- Ubiquitin protein ligases
- Deubiquitinating enzymes
- Ubiquitin specific proteases
- Φυσικές Επιστήμες
- Βιολογία
- Natural Sciences
- Biological Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20050